Clinical trial
Fluorouracil, Cisplatin, and Radiation Therapy or Gemcitabine and Oxaliplatin in…
NCT00304135 · Federation Francophone de Cancerologie Digestive, Other · Completed
Key facts
| NCT number | NCT00304135 |
|---|---|
| Title | Fluorouracil, Cisplatin, and Radiation Therapy or Gemcitabine and Oxaliplatin in Treating Patients With Nonmetastatic Biliary Tract Cancer That Cannot Be Removed By Surgery |
| Official title | Randomized Phase II-III Study of Chemoradiation With Fluorouracil and Cisplatin Versus Chemotherapy (Gemcitabine/Oxaliplatin) in Non Resectable But Non Metastatic Cancer of the Biliary Tract |
| Lead sponsor | Federation Francophone de Cancerologie Digestive, Other |
| Status | Completed |
| Phase | Phase 2/Phase 3 |
| Study type | Interventional |
| Conditions | Extrahepatic Bile Duct Cancer, Gallbladder Cancer, Liver Cancer |
| Intervention type | Drug |
| Interventions | cisplatin, gemcitabine hydrochloride, oxaliplatin |
| Enrollment | 34 |
| Start date | Oct 1, 2005 |
| Primary completion | Dec 1, 2012 |
| Completion | Dec 1, 2012 |
| First posted | Mar 17, 2006 |
| Last update posted | May 30, 2016 |
| Countries | France |
At a glance
- 10–99 Study sites
- No Results posted
- None Linked FDA submissions
Counts are shown as ranges. Exact figures, trends and every underlying record are available in Orca1.
About ClinicalTrials.gov studies
ClinicalTrials.gov is the U.S. National Library of Medicine's registry of clinical studies conducted around the world. Contact and investigator details are not shown here.
Source: U.S. National Library of Medicine (NLM), ClinicalTrials.gov · Source date: